[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 1936 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
1st Session
S. 1936
To require the Center for Medicare and Medicaid Innovation to test
allowing blood transfusions to be paid separately from the Medicare
hospice all-inclusive per diem payment.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
June 3, 2025
Ms. Rosen (for herself, Mr. Barrasso, and Ms. Baldwin) introduced the
following bill; which was read twice and referred to the Committee on
Finance
_______________________________________________________________________
A BILL
To require the Center for Medicare and Medicaid Innovation to test
allowing blood transfusions to be paid separately from the Medicare
hospice all-inclusive per diem payment.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Improving Access to Transfusion Care
for Hospice Patients Act of 2025''.
SEC. 2. CENTER FOR MEDICARE AND MEDICAID INNOVATION TESTING OF ALLOWING
BLOOD TRANSFUSIONS TO BE PAID SEPARATELY FROM THE
MEDICARE HOSPICE ALL-INCLUSIVE PER DIEM PAYMENT.
Section 1115A of the Social Security Act (42 U.S.C. 1315a) is
amended--
(1) in subsection (b)(2)(A), by adding at the end the
following new sentence: ``The models selected under this
subparagraph shall include the testing of the model described
in subsection (h).''; and
(2) by adding at the end the following new subsection:
``(h) Testing of Allowing Blood Transfusions To Be Paid Separately
From the Medicare Hospice All-Inclusive Per Diem Payment.--
``(1) In general.--Not later than 1 year after the date of
enactment of this subsection, the CMI shall establish and
implement a model under which blood transfusions furnished to
an individual receiving hospice care are paid separately from
the hospice all-inclusive per diem payment under section
1814(i). The separate payment amount for such blood transfusion
shall be the amount that would otherwise apply under title
XVIII if the transfusion was not furnished as part of hospice
care.
``(2) Requirements for evaluation.--In conducting any
evaluation of the model described in paragraph (1) pursuant to
subsection (b)(4), the CMI shall ensure it compares
participants under the model with similar patients outside of
the model with respect to the following metrics:
``(A) The number of chemotherapy services furnished
in the last 14 days of life.
``(B) Hospital utilization in the last 30 days of
life, including emergency department visits, in-patient
and observation status stays (including the length of
the stays), and intensive care unit (ICU) days.
``(C) How many days receiving hospice care before
the end of life.
``(D) The number of patients receiving hospice care
who received a transfusion compared to patients with
similar diagnoses not receiving hospice care.
``(E) The average frequency of transfusion for
patients receiving hospice care compared to patients
not receiving hospice care.
``(F) The number of transfusions for patients
receiving hospice care compared to patients not
receiving hospice care.
``(G) Other areas determined appropriate by the
CMI.''.
<all>